Utility of immunohistochemistry on bone marrow trephine biopsy for the diagnosis and classification of acute leukemia

Background: Bone marrow examination is an essential diagnostic tool in acute leukemia for the determination of lineage of blasts by flow cytometry or immunophenotyping. In cases of dry tap or where facilities of flow cytometry is not available, immunohistochemistry (IHC) on trephine biopsy sections...

Full description

Saved in:
Bibliographic Details
Main Authors: H Sudha Rani, Monalisa Hui, Megha S Uppin, Shantveer G Uppin, G Sadashivudu, Tara Roshni Paul
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2020-01-01
Series:Indian Journal of Medical and Paediatric Oncology
Subjects:
Online Access:http://www.ijmpo.org/article.asp?issn=0971-5851;year=2020;volume=41;issue=5;spage=683;epage=687;aulast=Rani
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849765355394695168
author H Sudha Rani
Monalisa Hui
Megha S Uppin
Shantveer G Uppin
G Sadashivudu
Tara Roshni Paul
author_facet H Sudha Rani
Monalisa Hui
Megha S Uppin
Shantveer G Uppin
G Sadashivudu
Tara Roshni Paul
author_sort H Sudha Rani
collection DOAJ
description Background: Bone marrow examination is an essential diagnostic tool in acute leukemia for the determination of lineage of blasts by flow cytometry or immunophenotyping. In cases of dry tap or where facilities of flow cytometry is not available, immunohistochemistry (IHC) on trephine biopsy sections can be used as a supportive tool to diagnose and classify acute leukemia. Materials and Methods: The giemsa-stained peripheral smears and bone marrow aspirate/imprints smears were retrospectively evaluated. IHC was done on trephine biopsy sections using a panel of antibodies which included CD34, MPO, CD117, Tdt, CD3, CD20, PAX5, and CD10 Results: Of the 29 cases diagnosed by IHC on trephine sections, 25 cases could be accurately classified based on the expression of myeloid and lymphoid markers. Majority of the acute lymphoblastic leukemia (ALL) were of B-cell lineage (81.25%), and almost half of the B-ALL were common acute lymphoblastic leukemia-associated antigen positive. Conclusion: IHC on trephine biopsy facilitates the confirmation and subtyping of leukemia in more than 85% cases. A limited panel of antibodies using CD34, MPO, TdT, CD3 CD20, PAX 5, and CD10 can be used for subtyping of leukemias in trephine biopsy sections, especially in centers with limited resources. It obviates the need for a repeat bone marrow procedure where material is not available for flow cytometry.
format Article
id doaj-art-c25ed9a31b844aec91f66eb6b2cea34e
institution DOAJ
issn 0971-5851
0975-2129
language English
publishDate 2020-01-01
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format Article
series Indian Journal of Medical and Paediatric Oncology
spelling doaj-art-c25ed9a31b844aec91f66eb6b2cea34e2025-08-20T03:04:53ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Medical and Paediatric Oncology0971-58510975-21292020-01-0141568368710.4103/ijmpo.ijmpo_216_19Utility of immunohistochemistry on bone marrow trephine biopsy for the diagnosis and classification of acute leukemiaH Sudha RaniMonalisa HuiMegha S UppinShantveer G UppinG SadashivuduTara Roshni PaulBackground: Bone marrow examination is an essential diagnostic tool in acute leukemia for the determination of lineage of blasts by flow cytometry or immunophenotyping. In cases of dry tap or where facilities of flow cytometry is not available, immunohistochemistry (IHC) on trephine biopsy sections can be used as a supportive tool to diagnose and classify acute leukemia. Materials and Methods: The giemsa-stained peripheral smears and bone marrow aspirate/imprints smears were retrospectively evaluated. IHC was done on trephine biopsy sections using a panel of antibodies which included CD34, MPO, CD117, Tdt, CD3, CD20, PAX5, and CD10 Results: Of the 29 cases diagnosed by IHC on trephine sections, 25 cases could be accurately classified based on the expression of myeloid and lymphoid markers. Majority of the acute lymphoblastic leukemia (ALL) were of B-cell lineage (81.25%), and almost half of the B-ALL were common acute lymphoblastic leukemia-associated antigen positive. Conclusion: IHC on trephine biopsy facilitates the confirmation and subtyping of leukemia in more than 85% cases. A limited panel of antibodies using CD34, MPO, TdT, CD3 CD20, PAX 5, and CD10 can be used for subtyping of leukemias in trephine biopsy sections, especially in centers with limited resources. It obviates the need for a repeat bone marrow procedure where material is not available for flow cytometry.http://www.ijmpo.org/article.asp?issn=0971-5851;year=2020;volume=41;issue=5;spage=683;epage=687;aulast=Raniacute leukemiaimmunohistochemistrytrephine biopsy
spellingShingle H Sudha Rani
Monalisa Hui
Megha S Uppin
Shantveer G Uppin
G Sadashivudu
Tara Roshni Paul
Utility of immunohistochemistry on bone marrow trephine biopsy for the diagnosis and classification of acute leukemia
Indian Journal of Medical and Paediatric Oncology
acute leukemia
immunohistochemistry
trephine biopsy
title Utility of immunohistochemistry on bone marrow trephine biopsy for the diagnosis and classification of acute leukemia
title_full Utility of immunohistochemistry on bone marrow trephine biopsy for the diagnosis and classification of acute leukemia
title_fullStr Utility of immunohistochemistry on bone marrow trephine biopsy for the diagnosis and classification of acute leukemia
title_full_unstemmed Utility of immunohistochemistry on bone marrow trephine biopsy for the diagnosis and classification of acute leukemia
title_short Utility of immunohistochemistry on bone marrow trephine biopsy for the diagnosis and classification of acute leukemia
title_sort utility of immunohistochemistry on bone marrow trephine biopsy for the diagnosis and classification of acute leukemia
topic acute leukemia
immunohistochemistry
trephine biopsy
url http://www.ijmpo.org/article.asp?issn=0971-5851;year=2020;volume=41;issue=5;spage=683;epage=687;aulast=Rani
work_keys_str_mv AT hsudharani utilityofimmunohistochemistryonbonemarrowtrephinebiopsyforthediagnosisandclassificationofacuteleukemia
AT monalisahui utilityofimmunohistochemistryonbonemarrowtrephinebiopsyforthediagnosisandclassificationofacuteleukemia
AT meghasuppin utilityofimmunohistochemistryonbonemarrowtrephinebiopsyforthediagnosisandclassificationofacuteleukemia
AT shantveerguppin utilityofimmunohistochemistryonbonemarrowtrephinebiopsyforthediagnosisandclassificationofacuteleukemia
AT gsadashivudu utilityofimmunohistochemistryonbonemarrowtrephinebiopsyforthediagnosisandclassificationofacuteleukemia
AT tararoshnipaul utilityofimmunohistochemistryonbonemarrowtrephinebiopsyforthediagnosisandclassificationofacuteleukemia